ASCO 2021 Prostate Cancer - Results from #80

Viewing 81-90 of 90 articles

ASCO 2021: The Efficacy of Enzalutamide (ENZA) Plus ADT on Bone Oligometastatic Hormone-Sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES

ASCO 2021: First-in-Human Study of TAS3681, an Oral Androgen Receptor Antagonist with AR and AR Splice Variant Downregulation Activity, in Patients with mCRPC Refractory to Abiraterone And/or Enzalutamide and Chemotherapy

ASCO 2021: PSMA-PET/CT Registry for Recurrent Prostate Cancer (PREP): Initial Findings from a Single Center

ASCO 2021: Validation of the Decipher Genomic Classifier in SAKK 09/10: A phase III Randomized Trial Of Dose-Escalated Salvage Radiotherapy After Radical Prostatectomy

ASCO 2021: Health-Related Quality of Life and Patient-Reported Outcomes at Final Analysis of the TITAN Study in Patients with Metastatic Castration-Sensitive Prostate Cancer

ASCO 2021: Immunogenic Priming with 177Lu-PSMA-617 Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer: A phase 1b study

ASCO 2021: PSMA-Targeted Imaging with 18F-DCFPyL-PET/CT in Patients with Biochemically Recurrent Prostate Cancer: A Phase 3 Study (CONDOR)—A Subanalysis of Correct Localization Rate and Positive Predictive Value by Standard of Truth

ASCO 2021: Urology Perspective: Application of Precision Health to High-Risk, Localized Disease

ASCO 2021: Medical Oncology Perspective: The Promise and Limitations of Precision Health in Metastatic Disease

ASCO 2021: The Application of the Niche: Genomic Medicine in Prostate Trials and Treatments

1
2
3
4
5

email news signup